AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
• Azitra reports Q3 2025 financial results • Dosed first patient in Phase 1/2 trial for ATR-04 program • Presented positive preclinical data for ATR-01 program • Raised $2.8M through equity line of credit with Alumni Capital LP
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet